Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 136 publications
Time-of-day of first checkpoint inhibitor dose influences clinical outcomes and immune responses in hepatocellular carcinoma.
Journal: Journal for immunotherapy of cancer
Published: February 02, 2026
Wnt signaling and the tumor microenvironment: implications for cancer progression and therapeutics.
Journal: Oncogene
Published: October 01, 2025
OPPORTUNITIES AND CHALLENGES FOR TARGETING CANCER METABOLISM.
Journal: Transactions of the American Clinical and Climatological Association
Published: August 07, 2025
Androgen Receptor Drives Polyamine Synthesis, Creating a Vulnerability for Prostate Cancer.
Journal: Cancer research
Published: April 07, 2025
DNAJ-PKAc induces metabolic rewiring and enhanced glutamine flux in fibrolamellar HCC.
Journal: Journal of hepatology
Published: February 17, 2025
Lineage dependence of the neuroblastoma surfaceome defines tumor cell state-dependent and -independent immunotherapeutic targets.
Journal: Neuro-oncology
Published: January 18, 2025
The HIF-2 transcription factor mediates resistance to ferroptosis in pancreatic cancer.
Journal: Molecular cell
Published: January 03, 2025
Androgen receptor drives polyamine synthesis creating a vulnerability for prostate cancer.
Journal: medRxiv : the preprint server for health sciences
Published: December 23, 2024
Imaging the uptake and metabolism of glutamine in prostate tumor models using CEST MRI.
Journal: Npj imaging
Published: October 31, 2024
Lineage-dependence of the neuroblastoma surfaceome defines tumor cell state-dependent and independent immunotherapeutic targets.
Journal: bioRxiv : the preprint server for biology
Published: July 15, 2024
Last Updated: 09/26/2026